Skip to main content

Mereo BioPharma Group plc

MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719714

No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Mereo BioPharma Group plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
56
+4 vs. Q2 2023
Shares held
70.5M
+7.56M (+12.0%) vs. Q2 2023
Total value
$90.4M
+$8.17M (+9.9%) vs. Q2 2023
New holders
10
13 more added
Sold out
6
15 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MREO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 56 institutions
Q1 2021: 67 institutionsQ2 2021: 72 institutionsQ3 2021: 63 institutionsQ4 2021: 73 institutionsQ1 2022: 60 institutionsQ2 2022: 64 institutionsQ3 2022: 63 institutionsQ4 2022: 61 institutionsQ1 2023: 58 institutionsQ2 2023: 53 institutionsQ3 2023: 56 institutionsQ4 2023: 64 institutionsQ1 2024: 80 institutionsQ2 2024: 79 institutionsQ3 2024: 77 institutionsQ4 2024: 91 institutionsQ1 2025: 90 institutionsQ2 2025: 86 institutionsQ3 2025: 84 institutionsQ4 2025: 70 institutionsQ1 2026: 63 institutionsQ2 2026: 60 institutions
Value heldQ3 2023: $90.4M
Q1 2021: $304.5MQ2 2021: $284.4MQ3 2021: $212.2MQ4 2021: $145.7MQ1 2022: $99.9MQ2 2022: $82.7MQ3 2022: $58.5MQ4 2022: $46.2MQ1 2023: $43.0MQ2 2023: $84.3MQ3 2023: $90.4MQ4 2023: $181.4MQ1 2024: $277.3MQ2 2024: $361.9MQ3 2024: $434.8MQ4 2024: $403.1MQ1 2025: $250.3MQ2 2025: $267.8MQ3 2025: $206.7MQ4 2025: $25.8MQ1 2026: $24.9MQ2 2026: $18.0M
Institutions holding MREO and their total value by quarter
QuarterHoldersValue
Q2 202660$18.0M
Q1 202663$24.9M
Q4 202570$25.8M
Q3 202584$206.7M
Q2 202586$267.8M
Q1 202590$250.3M
Q4 202491$403.1M
Q3 202477$434.8M
Q2 202479$361.9M
Q1 202480$277.3M
Q4 202364$181.4M
Q3 202356$90.4M
Q2 202353$84.3M
Q1 202358$43.0M
Q4 202261$46.2M
Q3 202263$58.5M
Q2 202264$82.7M
Q1 202260$99.9M
Q4 202173$145.7M
Q3 202163$212.2M
Q2 202172$284.4M
Q1 202167$304.5M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Mereo BioPharma Group plc; share changes are against Q2 2023.

Institutions holding MREO in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Rubric Capital Management LP11,616,120$15.0M0.63%00.0%Unchanged
Soleus Capital Management, L.P.9,677,419$12.5M1.26%+9,677,419New
Rock Springs Capital Management LP7,676,481$9.90M0.27%+634,090+9.0%Added
Suvretta Capital Management, LLC7,364,438$9.50M0.51%00.0%Unchanged
683 Capital Management, LLC6,000,000$7.74M0.78%+600,000+11.1%Added
Mangrove Partners5,531,547$7.14M0.73%00.0%Unchanged
Alkeon Capital Management LLC3,738,100$4.82M0.03%00.0%Unchanged
Tejara Capital Ltd3,215,001$4.15M2.36%+177,030+5.8%Added
Clearline Capital LP3,102,723$4.00M0.40%+1,157,683+59.5%Added
Citadel Advisors LLC2,242,425$2.89M0.00%+473,982+26.8%Added
Goldman Sachs Group Inc2,023,672$2.61M0.00%+41,266+2.1%Added
Renaissance Technologies LLC1,727,570$2.23M0.00%−51,202−2.9%Reduced
Millennium Management LLC1,243,585$1.60M0.00%+288,514+30.2%Added
DAFNA Capital Management LLC962,513$1.24M0.39%−46,500−4.6%Reduced
Adage Capital Partners GP, L.L.C.800,000$1.03M0.00%+800,000New
Monaco Asset Management SAM595,729$768.5K0.38%−110,000−15.6%Reduced
J. Goldman & Co LP445,485$574.7K0.03%+94,500+26.9%Added
Toroso Investments, LLC331,914$428.2K0.01%00.0%Unchanged
Formidable Asset Management, LLC331,914$428.2K0.09%+331,914New
Ikarian Capital, LLC591,676$191.3K0.07%−300,000−33.6%Reduced
Two Sigma Investments, LP142,602$184.0K0.00%−55,157−27.9%Reduced
JPMorgan Chase & Co132,801$171.3K0.00%−171,230−56.3%Reduced
Schonfeld Strategic Advisors LLC130,600$168.5K0.00%+100+0.1%Added
Boothbay Fund Management, LLC120,584$155.6K0.01%−61,140−33.6%Reduced
Susquehanna International Group, LLP103,270$133.2K0.00%+103,270New
Geode Capital Management, LLC96,630$124.7K0.00%00.0%Unchanged
Primecap Management Co79,000$101.9K0.00%−78,700−49.9%Reduced
Forefront Analytics, LLC65,649$84.7K0.05%−17,100−20.7%Reduced
Clear Harbor Asset Management, LLC63,754$82.2K0.01%+7,000+12.3%Added
HSBC Holdings PLC58,217$75.1K0.00%00.0%Unchanged
NEOS Investment Management LLC41,328$53.3K0.01%+41,328New
Virtu Financial LLC34,093$44.0K0.00%+34,093New
PFG Investments, LLC30,000$38.7K0.01%−1,500−4.8%Reduced
Resources Investment Advisors, LLC.26,300$33.9K0.00%−12,762−32.7%Reduced
Privium Fund Management (UK) Ltd24,726$32.4K0.03%−152,474−86.0%Reduced
Centiva Capital, LP25,000$32.3K0.00%00.0%Unchanged
Level Four Advisory Services, LLC20,000$25.8K0.00%00.0%Unchanged
Jane Street Group, LLC17,285$22.3K0.00%−1,461−7.8%Reduced
Creative Planning15,820$20.4K0.00%+15,820New
Arcus Capital Partners, LLC15,000$19.4K0.01%+15,000New
Golden State Equity Partners14,400$18.6K0.01%00.0%Unchanged
Oppenheimer & Co Inc14,000$18.1K0.00%00.0%Unchanged
XTX Topco Ltd11,313$14.6K0.00%+11,313New
Bank of America Corp9,218$11.9K0.00%+9,217+921,700.0%Added
Morgan Stanley6,693$8.63K0.00%−2,326−25.8%Reduced
SRS Capital Advisors, Inc.4,000$5.16K0.00%00.0%Unchanged
Rhumbline Advisers3,598$4.64K0.00%+340+10.4%Added
Allworth Financial LP1,500$1.94K0.00%00.0%Unchanged
Sit Investment Associates Inc970$1.00K0.00%00.0%Unchanged
New England Capital Financial Advisors LLC300$3870.00%00.0%Unchanged
Wells Fargo & Company230$2960.00%−5,000−95.6%Reduced
Barclays PLC76$980.00%+38+100.0%Added
Plante Moran Financial Advisors, LLC48$620.00%00.0%Unchanged
US Bancorp13$170.00%00.0%Unchanged
BNP Paribas Arbitrage, SA3$40.00%00.0%Unchanged
Highlander Capital Management, LLC127$00.00%+127New
Baker Bros. Advisors LP0$00.00%−3,554,979−100.0%Sold out
Boxer Capital, LLC0$00.00%−2,250,000−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−74,727−100.0%Sold out
Newbridge Financial Services Group, Inc.0$00.00%−9,500−100.0%Sold out
UBS Group AG0$00.00%−2,491−100.0%Sold out
Royal Bank of Canada0$00.00%−14−100.0%Sold out
Tekla Capital Management LLC––––Not filed